191 related articles for article (PubMed ID: 38125815)
1. Assessment of the response to systemic treatment of colorectal liver metastases on cross-sectional imaging - a systematic review.
Morawska I; Cieszanowski A
Pol J Radiol; 2023; 88():e512. PubMed ID: 38125815
[TBL] [Abstract][Full Text] [Related]
2. Disappearing Colorectal Liver Metastases: Do We Really Need a Ghostbuster?
Anselmo A; Cascone C; Siragusa L; Sensi B; Materazzo M; Riccetti C; Bacchiocchi G; Ielpo B; Rosso E; Tisone G
Healthcare (Basel); 2022 Sep; 10(10):. PubMed ID: 36292345
[TBL] [Abstract][Full Text] [Related]
3. Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI.
Liu LH; Zhou GF; Lv H; Wang ZC; Rao SX; Zeng MS
Eur Radiol; 2021 Aug; 31(8):5640-5649. PubMed ID: 33449175
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of liver tumour response by imaging.
Gregory J; Dioguardi Burgio M; Corrias G; Vilgrain V; Ronot M
JHEP Rep; 2020 Jun; 2(3):100100. PubMed ID: 32514496
[TBL] [Abstract][Full Text] [Related]
5. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review.
Barimani D; Kauppila JH; Sturesson C; Sparrelid E
World J Surg Oncol; 2020 Oct; 18(1):264. PubMed ID: 33032620
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
7. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI for predicting and assessing treatment response of liver metastases from CRC - A systematic review and meta-analysis.
Sobeh T; Inbar Y; Apter S; Soffer S; Anteby R; Kraus M; Konen E; Klang E
Eur J Radiol; 2023 Jun; 163():110810. PubMed ID: 37075628
[TBL] [Abstract][Full Text] [Related]
9. Disappearing liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Paredes AZ; Moris D; Gavriatopoulou M; Cloyd JM; Pawlik TM
Surg Oncol; 2019 Jun; 29():7-13. PubMed ID: 31196496
[TBL] [Abstract][Full Text] [Related]
10. [Clinical research progress on disappearing colorectal liver metastases].
Pan SR; Chen ZY; Zhao K; Liu YC; Wang PY
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):1028-1034. PubMed ID: 34823305
[TBL] [Abstract][Full Text] [Related]
11. Intravoxel incoherent motion diffusion-weighted imaging for early assessment of combined anti-angiogenic/chemotherapy for colorectal cancer liver metastases.
Wu H; Li B; Yang Z; Ji H; Guo Y; Lin J; Wang X
Quant Imaging Med Surg; 2022 Sep; 12(9):4587-4600. PubMed ID: 36060592
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemotherapy.
Zhu HB; Xu D; Zhang XY; Li XT; Xing BC; Sun YS
Ann Surg Oncol; 2022 Jun; 29(6):3938-3949. PubMed ID: 35013857
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
Wagner M; Ronot M; Doblas S; Giraudeau C; Van Beers B; Belghiti J; Paradis V; Vilgrain V
Eur Radiol; 2016 Jan; 26(1):206-15. PubMed ID: 25933743
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
[TBL] [Abstract][Full Text] [Related]
15. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
[TBL] [Abstract][Full Text] [Related]
16. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
[TBL] [Abstract][Full Text] [Related]
17. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review.
Bolhuis K; Kos M; van Oijen MGH; Swijnenburg RJ; Punt CJA
Eur J Cancer; 2020 Dec; 141():225-238. PubMed ID: 33189037
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
19. When is a Ghost Really Gone? A Systematic Review and Meta-analysis of the Accuracy of Imaging Modalities to Predict Complete Pathological Response of Colorectal Cancer Liver Metastases After Chemotherapy.
Muaddi H; Silva S; Choi WJ; Coburn N; Hallet J; Law C; Cheung H; Karanicolas PJ
Ann Surg Oncol; 2021 Oct; 28(11):6805-6813. PubMed ID: 33772391
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Outcome of Disappearance or Small Remnants of Colorectal Liver Metastases during First-Line Chemotherapy on Hepatobiliary Contrast-Enhanced and Diffusion-Weighted MR Imaging.
Boraschi P; Moretto R; Donati F; Borelli B; Mercogliano G; Giugliano L; Boccaccino A; Della Pina MC; Colombatto P; Signori S; Masi G; Cremolini C; Urbani L
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]